Delayed anxiety and depressive morbidity among dengue patients in a multi-ethnic urban setting: first report from Sri Lanka

Abstract

BackgroundAlthough the physical consequences of dengue are well documented, delayed psychological co-morbidities are not well studied to date. Therefore, the objective of the present study was to determine the prevalence of depressive, anxiety and stress symptoms among past dengue patients.MethodsA community-based, case–control study in a multi-ethnic urban setting was conducted in Sri Lanka involving adults who were diagnosed to have dengue fever by a positive dengue IgM antibody response between 6 and 24 months ago. Self-administered Depression, Anxiety and Stress Scale (DASS-21), Centre for Epidemiological Studies Depression Scale (CESD-20) and a structured clinical interview by a psychiatrist were done in the patients and in an age and gender-matched control group.ResultsFifty-three participants each in the patient (mean age 42.9 years, SD 15.5) and control (mean age 41.6 years, SD 15.3) groups were surveyed. The ages ranged from 18 to 70 years and 64.2% were females. The majority (90.6%; n = 48) of the individuals had been diagnosed with dengue fever followed by dengue haemorrhagic fever (9.4% n = 5). Dengue patients had higher DASS-21 mean depressive scores (means 11.7/9.4, SD 6.4/4.0, t = 2.2, p = .028), anxiety scores (means 10.7/7.2, SD 6.8/1.8, t = 3.6, p = .0005), stress scores (means 12.0/8.8, SD 5.3/3.5, t = 3.6, p = .0004) and CESD-20 scores (means 16.1/11.7, SD 9.4/7.3, t = 2.6, p = .008) than controls. The DSM-5 depressive disorder was clinically detected by the psychiatrist among 15.1 and 7.5% in patient and control groups (OR 2.1; CI .5–7.7; p = .22). Limitations: a limitation is the small sample size.ConclusionPatients with past dengue had significantly higher depressive, anxiety and stress symptoms than the control group according to the DASS-21 and CESD-20 tools. To our knowledge, this is the first report on delayed psychological morbidity related to dengue. This may warrant healthcare professionals to incorporate mental counselling for dengue patients.

Measuring Consumer Willingness to Pay to Reduce Health Risks of Contracting Dengue Fever

“…Some studies have assessed WTP to reduce rates of illness or death [26][27][28][29][30], but there has been no assessment of psychological health risks and WTP. Gunathilaka et al [31] studied the impact of dengue fever on mental health in Sri Lanka, and pointed out that if people suffer from dengue fever, psychiatric manifestations may occur, such as depression, anxiety, and pain. To overcome this research gap, this study considered psychological health risks.…”

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

“…Furthermore, preclinical to An effective DENV antiviral is an essential countermeasure needed to control dengue outbreaks. Treatment of patients with a DENV antiviral could decrease viremia, which could potentially decrease painful and debilitating symptoms associated with DF and reduce some of the long-lasting effects of DENV infection including fatigue (51) and anxiety and depression (52). A decrease in viremia could also result in a decrease in the prevalence of DHS and DSS.…”

Psychosocial reactions of Pakistani Students towards COVID-19: A prevalence study

“…At a time of sudden and severe stress, we observe two extreme reactions. 19,20 Some overreact with panic measures and others deny the danger and perhaps pretend nothing is going to happen to them. Most of us move from one reaction to the other 21 .…”